Histogen Inc Quick Ratio (HSTO) starting from the third quarter 2023 to third quarter 2022, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Histogen Inc   (HSTO)

Histogen Inc 's Quick Ratio

HSTO's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the third quarter 2023, Quick Ratio fell to 3.39 below Histogen Inc average.

Within Major Pharmaceutical Preparations industry 277 other companies have achieved higher Quick Ratio than Histogen Inc in third quarter 2023. While Quick Ratio total ranking in the third quarter 2023 has deteriorated compared to the prior quarter from 250 to 943.

Explain Quick Ratio?
How much Cash & cash equivalents HSTO´s has?
What are HSTO´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

HSTO Quick Ratio (Sep 30 2023)
Q3		 (Jun 30 2023)
Q2		 (Mar 31 2023)
Q1		 (Dec 31 2022)
Q4		 (Sep 30 2022)
Q3
Y / Y Current Liabilities Change 14.92 % -23.89 % -59.29 % -57.25 % -54.3 %
Y / Y Cash & cash equivalent Change -68.57 % -42.38 % -45.89 % -35.19 % -24.27 %
Quick Ratio MRQ 3.39 10.31 8.87 12.16 12.41
HSTO's Total Ranking # 943 # 250 # 405 # 195 # 274
Seq. Current Liabilities Change 91.48 % -35.35 % 9.34 % -15.09 % 26.81 %
Seq. Cash & cash equivalent Change -37 % -24.84 % -20.24 % -16.79 % 15.51 %



Quick Ratio third quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 278
Healthcare Sector # 474
Overall Market # 943


Quick Ratio Statistics
High Average Low
20 7.87 1.31
(Dec 31 2013)   (Jun 30 2013)




Financial Statements
Histogen Inc 's Current Liabilities $ 1 Millions Visit HSTO's Balance sheet
Histogen Inc 's Cash & cash equivalent $ 5 Millions Visit HSTO's Balance sheet
Source of HSTO's Sales Visit HSTO's Sales by Geography


Cumulative Histogen Inc 's Quick Ratio

HSTO's Quick Ratio for the trailling 12 Months

HSTO Quick Ratio

 (Sep 30 2023)
12 Months		 (Jun 30 2023)
12 Months		 (Mar 31 2023)
12 Months		 (Dec 31 2022)
12 Months		 (Sep 30 2022)
12 Months
Y / Y Current Liabilities TTM Growth -41.76 % -53.37 % -56.88 % -34.77 % -23.62 %
Y / Y Cash & cash equivalent TTM Growth -47.24 % -36.24 % -37.99 % -31.02 % -10.13 %
Quick Ratio TTM 8.12 11 11.69 9.9 8.97
Total Ranking TTM # 3756 # 3148 # 3271 # 2197 # 3349
Seq. Current Liabilities TTM Growth 4.42 % -5.28 % -27.49 % -18.78 % -16.41 %
Seq. Cash & cash equivalent TTM Growth -22.9 % -10.91 % -14.34 % -10.33 % -6.82 %

Quick ratio ranking by company, industry and sector >> Back to HSTO Financial Strength Comparisons >> Go to Compare HSTO Quick Ratio to its Competitors

On the trailing twelve months basis Due to jump in Current Liabilities in the Q3 2023 to $1.35 millions, cumulative Quick Ratio decreased to 8.12 above the HSTO average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 529 other companies have achieved higher Quick Ratio than Histogen Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2023 from 3148 to 3756.

Explain Quick Ratio?
How much Cash & cash equivalents HSTO´s has?
What are HSTO´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 530
Healthcare Sector # 1048
Within the Market # 3756


trailing twelve months Quick Ratio Statistics
High Average Low
11.17 5.97 2.1
(Mar 31 2016)   (Mar 31 2019)




Companies with similar Quick Ratio in the quarter ending Sep 30 2023, within Major Pharmaceutical Preparations Industry Quick RatioSep 30 2023 MRQ Cash & cash equivalentSep 30 2023 MRQ Current Liabilities
Adicet Bio Inc   9.27 $ 183.257  Millions$ 19.768  Millions
Onkure Therapeutics Inc   9.26 $ 125.614  Millions$ 13.563  Millions
Gh Research Plc  9.19 $ 86.439  Millions$ 9.408  Millions
Jade Biosciences Inc   9.18 $ 135.199  Millions$ 14.725  Millions
Xenetic Biosciences Inc   9.15 $ 9.776  Millions$ 1.069  Millions
Werewolf Therapeutics Inc   9.01 $ 130.058  Millions$ 14.439  Millions
Igm Biosciences Inc   9.01 $ 386.991  Millions$ 42.965  Millions
Cytokinetics Incorporated  8.91 $ 539.239  Millions$ 60.487  Millions
Phathom Pharmaceuticals Inc   8.91 $ 213.677  Millions$ 23.979  Millions
Generation Bio Co   8.87 $ 291.025  Millions$ 32.819  Millions
Point Biopharma Global Inc   8.77 $ 339.163  Millions$ 38.666  Millions
Zentalis Pharmaceuticals Inc   8.77 $ 516.637  Millions$ 58.918  Millions
Bullfrog Ai Holdings Inc   8.64 $ 3.856  Millions$ 0.446  Millions
Spruce Biosciences Inc   8.59 $ 108.032  Millions$ 12.572  Millions
Cerevel Therapeutics Holdings Inc   8.59 $ 676.882  Millions$ 78.838  Millions
Tff Pharmaceuticals Inc  8.52 $ 9.726  Millions$ 1.142  Millions
Rapt Therapeutics Inc   8.46 $ 184.777  Millions$ 21.849  Millions
Scpharmaceuticals Inc   8.43 $ 90.198  Millions$ 10.703  Millions
Sol gel Technologies Ltd   8.40 $ 37.996  Millions$ 4.522  Millions
Shuttle Pharmaceuticals Holdings Inc   8.40 $ 6.807  Millions$ 0.810  Millions
An2 Therapeutics Inc   8.35 $ 123.818  Millions$ 14.836  Millions
Longboard Pharmaceuticals Inc   8.35 $ 56.016  Millions$ 6.712  Millions
Tango Therapeutics Inc   8.29 $ 359.880  Millions$ 43.416  Millions
Allakos Inc   8.27 $ 193.908  Millions$ 23.450  Millions
Rani Therapeutics Holdings Inc   8.24 $ 60.526  Millions$ 7.345  Millions
Oncolytics Biotech Inc   8.24 $ 26.743  Millions$ 3.246  Millions
Bicycle Therapeutics Plc  8.20 $ 572.086  Millions$ 69.736  Millions
Filana Therapeutics Inc   8.17 $ 142.350  Millions$ 17.414  Millions
Oncternal Therapeutics Inc   8.06 $ 40.305  Millions$ 5.001  Millions
Centessa Pharmaceuticals Plc  8.05 $ 281.341  Millions$ 34.954  Millions

Date modified: 2026-09-18T13:11:05+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.